This is a preview of subscription content, log in via an institution to check access.
Notes
2015 US dollars
Reference
Lam SW, et al. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer. Pharmacotherapy : 12 Nov 2016. Available from: URL: http://doi.org/10.1002/phar.1870
Rights and permissions
About this article
Cite this article
Irinotecan cost effective for gastric cancer. PharmacoEcon Outcomes News 767, 15 (2016). https://doi.org/10.1007/s40274-016-3575-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3575-2